ClearPoint Neuro, Inc. entered into a Third Omnibus Amendment with PTC Therapeutics, Inc. and Petrichor Opportunities Fund I LP to replace LIBOR with SOFR as the interest rate benchmark.
AI Assistant
CLEARPOINT NEURO INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.